CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 97 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $112,000 | -81.3% | 13,500 | -58.3% | 0.02% | -55.8% |
| Q3 2018 | $599,000 | -76.9% | 32,385 | -71.4% | 0.04% | -77.0% |
| Q2 2018 | $2,591,000 | -13.0% | 113,345 | +8.3% | 0.19% | -16.5% |
| Q1 2018 | $2,979,000 | -28.0% | 104,706 | -46.6% | 0.22% | -26.3% |
| Q4 2017 | $4,138,000 | +39.0% | 196,032 | +19.6% | 0.30% | +49.8% |
| Q3 2017 | $2,977,000 | – | 163,852 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,559,722 | $23,672,000 | 1.29% |
| Congress Park Capital LLC | 78,561 | $522,000 | 0.32% |
| Exane Asset Management | 63,820 | $424,403,000 | 0.28% |
| Perceptive Advisors | 2,577,043 | $17,137,000 | 0.25% |
| RTW INVESTMENTS, LP | 1,526,003 | $10,148,000 | 0.24% |
| Jackson Creek Investment Advisors LLC | 80,504 | $535,000 | 0.24% |
| HARBOURVEST PARTNERS LLC | 79,193 | $527,000 | 0.20% |
| TANG CAPITAL MANAGEMENT LLC | 112,880 | $751,000 | 0.14% |
| Virtus ETF Advisers LLC | 38,721 | $257,000 | 0.14% |
| GLOBEFLEX CAPITAL L P | 69,435 | $462,000 | 0.12% |